✨
AI Summary
- Discussing a trial comparing ixekizumab with tirzepatide vs. ixekizumab alone.
- Focus on psoriatic arthritis with overweight or obesity.
- Achieving greater disease control with combination therapy.
The Immune-Mediated Inflammatory Disease Forum